X

Pfizer inc (PFE) U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer inc (NYSE: PFE) FY 2026 Other Release

Newsdesk: